A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
By M. Landon, C. Spong, E. Thom, M. Carpenter, S. Ramin, B. Casey, R. Wapner, M. Varner, D. Rouse, J. Thorp and 9 more. New England Journal of Medicine, 2009
1,983 citations recorded by the source corpus.
BACKGROUND It is uncertain whether treatment of mild gestational diabetes mellitus improves pregnancy outcomes. METHODS Women who were in the 24th to 31st week of gestation and who met the criteria for mild gestational diabetes mellitus (i.e., an abnormal result on an oral glucose-tolerance test but a fasting glucose level below 95 mg per deciliter [5.3 mmol per liter]) were randomly assigned to usual prenatal care (control group) or dietary intervention, self-monitoring of blood glucose, and insulin therapy, if necessary (treatment group). The primary outcome was a composite of stillbirth or perinatal death and neonatal complications, including hyperbilirubinemia, hypoglycemia, hyperinsulinemia, and birth trauma. RESULTS A total of 958 women were randomly assigned to a study group — 485 to the treatment group and 473 to the control group. We observed no significant difference between groups in the frequency of the composite outcome (32.4% and 37.0% in the treatment and control groups, respectively; P = 0.14). There were no perinatal deaths. However, there were significant reductions with treatment as compared with usual care in several prespecified secondary outcomes, including mean birth weight (3302 vs. 3408 g), neonatal fat mass (427 vs. 464 g), the frequency of large-for-gestational-age infants (7.1% vs. 14.5%), birth weight greater than 4000 g (5.9% vs. 14.3%), shoulder dystocia (1.5% vs. 4.0%), and cesarean delivery (26.9% vs. 33.8%). Treatment of gestational diabetes mellitus, as compared with usual care, was also associated with reduced rates of preeclampsia and gestational hypertension (combined rates for the two conditions, 8.6% vs. 13.6%; P = 0.01). CONCLUSIONS Although treatment of mild gestational diabetes mellitus did not significantly reduce the frequency of a composite outcome that included stillbirth or perinatal death and several neonatal complications, it did reduce the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders.
Subfields: Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology
View Paper: https://www.semanticscholar.org/paper/8d7322ba897d3d308b21cd6fceeb2c38dce4f724
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Obstetrics and Gynecology
Citations in the corpus
- Triangulation in aetiological epidemiology (2016, methodology): “This enabled us to compare results from multivariable regression in pregnancy cohorts,55 a cross-context comparison using data from the Born in Bradford (BiB) study,56 an MR study55 and IV analyses of an intermediate (fasting glucose) in an RCT.57 Table 3 Figure 2.”
- Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. (2002, background): “Both studies found that treatment of GDM can reduce both serious adverse outcomes and the frequency of large babies (macrosomia) (174,175).”
- Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization Guideline. (2014, background): “[46] which randomized only women with fasting plasma gluco-”
- Diagnosis and Classification of Diabetes Mellitus The information that follows is based largely on the reports of the Expert Committee on the Diagnosis and Classification of Diabetes (Diabetes Care 20:1183–1197, 1997, and Diabetes Care 26:3160–3167, 2003). (2006, background): “Expected benefits to their pregnancies and offspring is inferred from intervention trials that focused on women with more mild hyperglycemia than identified using older GDM diagnostic criteria and that found modest benefits (15,16).”
- Diagnosis and Classification of Diabetes Mellitus (2011, background): “Expected benefits to their pregnancies and offspring is inferred from intervention trials that focused on women with more mild hyperglycemia than identified using older GDM diagnostic criteria and that found modest benefits (13,14).”
- The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care # (2015, background): “[26] demonstrated that newborns of diabetic mothers suffered from hypoglycemia and hypothesized that this was due to fetal hyperinsulinism as a result of increased transplacental transfer of sugar.”